Edge biomarkers for classification and prediction of phenotypes

Science China Life Sciences

Volumn 57, Issue 11, 2014, Pages 1103-1114

  Zeng, Tao ^a   Zhang, WanWei ^a   Yu, XiangTian ^a,b   Liu, XiaoPing ^a   Li, MeiYi ^a   Liu, Rui ^c   Chen, LuoNan ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b SHANDONG UNIVERSITY   (China)

^c SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

biomarker; classification; disease diagnosis; disease prognosis; dynamical network biomarker; edge biomarker; phenotype; prediction

Indexed keywords

BIOLOGICAL MARKER;

ALGORITHM; ARTIFICIAL INTELLIGENCE; BIOLOGY; COMPUTER SIMULATION; EARLY DIAGNOSIS; HUMAN; METABOLISM; PHENOTYPE; PROCEDURES; PROGNOSIS; PROTEIN ANALYSIS;

ALGORITHMS; ARTIFICIAL INTELLIGENCE; BIOMARKERS; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; EARLY DIAGNOSIS; HUMANS; PHENOTYPE; PROGNOSIS; PROTEIN INTERACTION MAPPING;

EID: 84922004018     PISSN: 16747305     EISSN: 18691889     Source Type: Journal    
DOI: 10.1007/s11427-014-4757-4     Document Type: Article

References (67)

1. Hood L, Flores M. A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. N Biotechnol, 2012, 29: 613–624
2. Hood L, Friend SH. Predictive, personalized, preventive, participatory (P4) cancer medicine. Nat Rev Clin Oncol, 2011, 8: 184–187
3. Auffray C, Charron D, Hood L. Predictive, preventive, personalized and participatory medicine: back to the future. Genome Med, 2010, 2: 57
4. Zeng T, Sun SY, Wang Y, Zhu H, Chen L. Network biomarkers reveal dysfunctional gene regulations during disease progression. FEBS J, 2013, doi:10.1111/febs.12536
5. Zhong Q, Simonis N, Li QR, Charloteaux B, Heuze F, Klitgord N, Tam S, Yu H, Venkatesan K, Mou D, Swearingen V, Yildirim MA, Yan H, Dricot A, Szeto D, Lin C, Hao T, Fan C, Milstein S, Dupuy D, Brasseur R, Hill DE, Cusick ME, Vidal M. Edgetic perturbation models of human inherited disorders. Mol Syst Biol, 2009, 5: 321
6. Zhang W, Zeng T, Chen L. EdgeMarker: identifying differentially correlated molecule pairs as edge-biomarkers. J Theor Biol, 2014, doi:10.1016/j.jtbi.2014.05.041
7. Chen L, Liu R, Liu ZP, Li M, Aihara K. Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers. Sci Rep, 2012, 2: 342
8. Liu R, Li M, Liu ZP, Wu J, Chen L, Aihara K. Identifying critical transitions and their leading biomolecular networks in complex diseases. Sci Rep, 2012, 2: 813
9. Liu R, Wang X, Aihara K, Chen L. Early diagnosis of complex diseases by molecular biomarkers, network biomarkers, and dynamical network biomarkers. Med Res Rev, 2013, doi:10.1002/med.21293
10. Liu R, Yu X, Liu X, Xu D, Aihara K, Chen L. Identifying critical transitions of complex diseases based on a single sample. Bioinformatics, 2014, doi:10.1093/bioinformatics/btu084
11. Li M, Zeng T, Liu R, Chen L. Detecting tissue-specific early warning signals for complex diseases based on dynamical network biomarkers: study of type 2 diabetes by cross-tissue analysis. Brief Bioinform, 2013, doi: 10.1093/bib/bbt1027
12. Welcsh PL, King MC. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum Mol Genet, 2001, 10: 705–713
13. Wang-Sattler R, Yu Z, Herder C, Messias AC, Floegel A, He Y, Heim K, Campillos M, Holzapfel C, Thorand B, Grallert H, Xu T, Bader E, Huth C, Mittelstrass K, Döring A, Meisinger C, Gieger C, Prehn C, Roemisch-Margl W, Carstensen M, Xie L, Yamanaka-Okumura H, Xing G, Ceglarek U, Thiery J, Giani G, Lickert H, Lin X, Li Y, Boeing H, Joost HG, de Angelis MH, Rathmann W, Suhre K, Prokisch H, Peters A, Meitinger T, Roden M, Wichmann HE, Pischon T, Adamski J, Illig T. Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol, 2012, 8: 615
14. Wemmie JA, Taugher RJ, Kreple CJ. Acid-sensing ion channels in pain and disease. Nat Rev Neurosci, 2013, 14: 461–471
15. Lampertico P, Vigano M, Cheroni C, Facchetti F, Invernizzi F, Valveri V, Soffredini R, Abrignani S, de Francesco R, Colombo M. IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B. Hepatology, 2013, 57: 890–896
16. Joshita S, Umemura T, Katsuyama Y, Ichikawa Y, Kimura T, Morita S, Kamijo A, Komatsu M, Ichijo T, Matsumoto A, Yoshizawa K, Kamijo N, Ota M, Tanaka E. Association of IL28B gene polymorphism with development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C virus infection. Hum Immunol, 2012, 73: 298–300
17. Akavia UD, Litvin O, Kim J, Sanchez-Garcia F, Kotliar D, Causton HC, Pochanard P, Mozes E, Garraway LA, Pe’er D. An integrated approach to uncover drivers of cancer. Cell, 2010, 143: 1005–1017
18. Metzker ML. Sequencing technologies-the next generation. Nat Rev Genet, 2010, 11: 31–46
19. Schadt EE. Molecular networks as sensors and drivers of common human diseases. Nature, 2009, 461: 218–223
20. Ren X, Wang Y, Chen L, Zhang XS, Jin Q. ellipsoidFN: a tool for identifying a heterogeneous set of cancer biomarkers based on gene expressions. Nucleic Acids Res, 2013, 41: e53
21. Pritchard JK. Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet, 2001, 69: 124–137
22. Jorde LB. Linkage disequilibrium and the search for complex disease genes. Genome Res, 2000, 10: 1435–1444
23. Stower H. Complex disease: family history versus SNPs for disease predictions. Nat Rev Genet, 2012, 13: 827
24. van’t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH. Gene expression profiling predicts clinical outcome of breast cancer. Nature, 2002, 415: 530–536
25. Li J, Lenferink AE, Deng Y, Collins C, Cui Q, Purisima EO, O’Connor-McCourt MD, Wang E. Identification of high-quality cancer prognostic markers and metastasis network modules. Nat Commun, 2010, 1: 34
26. Gormley M, Dampier W, Ertel A, Karacali B, Tozeren A. Prediction potential of candidate biomarker sets identified and validated on gene expression data from multiple datasets. BMC Bioinformatics, 2007, 8: 415
27. Koiol JA, Feng AC, Jia Z, Wang Y, Goodison S, McClelland M, Mercola D. The wisdom of the commons: ensemble tree classifiers for prostate cancer prognosis. Bioinformatics, 2009, 25: 54–60
28. Holec M, Klema J, Zelezny F, Tolar J. Comparative evaluation of set-level techniques in predictive classification of gene expression samples. BMC Bioinformatics, 2012, 13(Suppl 10): S15
29. Lee S, Kim J. A comparative study on gene-set analysis methods for assessing differential expression associated with the survival phenotype. BMC Bioinformatics, 2011, 12: 377
30. Abraham G, Kowalczyk A, Loi S, Haviv I, Zobel J. Prediction of breast cancer prognosis using gene set statistics provides signature stability and biological context. BMC Bioinformatics, 2010, 11: 277
31. Levine DM, Haynor DR, Castle JC, Stepaniants SB, Pellegrini M, Mao M, Johnson JM. Pathway and gene-set activation measurement from mRNA expression data: the tissue distribution of human pathways. Genome Biol, 2006, 7: R93
32. Lee E, Chuang HY, Kim JW, Ideker T, Lee D. Inferring pathway activity toward precise disease classification. PLoS Comput Biol, 2008, 4: e1000217
33. Barabasi AL, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet, 2011, 12: 56–68
34. Kreeger PK, Lauffenburger DA. Cancer systems biology: a network modeling perspective. Carcinogenesis, 2010, 31: 2–8
35. Drier Y, Sheffer M, Domany E. Pathway-based personalized analysis of cancer. Proc Natl Acad Sci USA, 2013, 110: 6388–6393
36. Chuang HY, Lee E, Liu YT, Lee D, Ideker T. Network-based classification of breast cancer metastasis. Mol Syst Biol, 2007, 3: 140
37. Dao P, Wang K, Collins C, Ester M, Lapuk A, Sahinalp SC. Optimally discriminative subnetwork markers predict response to chemotherapy. Bioinformatics, 2011, 27: i205–213
38. He D, Liu ZP, Chen L. Identification of dysfunctional modules and disease genes in congenital heart disease by a network-based approach. BMC Genomics, 2011, 12: 592
39. Eddy JA, Hood L, Price ND, Geman D. Identifying tightly regulated and variably expressed networks by Differential Rank Conservation (DIRAC). PLoS Comput Biol, 2010, 6: e1000792
40. Jin G, Zhou X, Cui K, Zhang XS, Chen L, Wong ST. Cross-platform method for identifying candidate network biomarkers for prostate cancer. IET Syst Biol, 2009, 3: 505–512
41. Winter C, Kristiansen G, Kersting S, Roy J, Aust D, Knosel T, Rummele P, Jahnke B, Hentrich V, Ruckert F, Niedergethmann M, Weichert W, Bahra M, Schlitt HJ, Settmacher U, Friess H, Büchler M, Saeger HD, Schroeder M, Pilarsky C, Grützmann R. Google goes cancer: improving outcome prediction for cancer patients by network-based ranking of marker genes. PLoS Comput Biol, 2012, 8: e1002511
42. Jiao Y, Lawler K, Patel GS, Purushotham A, Jones AF, Grigoriadis A, Tutt A, Ng T, Teschendorff AE. DART: denoising algorithm based on relevance network topology improves molecular pathway activity inference. BMC Bioinformatics, 2011, 12: 403
43. Wen Z, Liu ZP, Liu Z, Zhang Y, Chen L. An integrated approach to identify causal network modules of complex diseases with application to colorectal cancer. J Am Med Inform Assoc, 2013, 20: 659–667
44. Hofree M, Shen JP, Carter H, Gross A, Ideker T. Network-based stratification of tumor mutations. Nat Methods, 2013, 10: 1108–1115
45. Dutkowski J, Ideker T. Protein networks as logic functions in development and cancer. PLoS Comput Biol, 2011, 7: e1002180
46. Liu X, Liu ZP, Zhao XM, Chen L. Identifying disease genes and module biomarkers by differential interactions. J Am Med Inform Assoc, 2012, 19: 241–248
47. Taylor IW, Linding R, Warde-Farley D, Liu Y, Pesquita C, Faria D, Bull S, Pawson T, Morris Q, Wrana JL. Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nat Biotechnol, 2009, 27: 199–204
48. Wang YC, Chen BS. A network-based biomarker approach for molecular investigation and diagnosis of lung cancer. BMC Med Genomics, 2011, 4: 2
49. Qian L, Zheng H, Zhou H, Qin R, Li J. classification of time series gene expression in clinical studies via integration of biological network. PLoS One, 2013, 8: e58383
50. Yu X, Li G, Chen L. Prediction and early diagnosis of complex diseases by edge-network. Bioinformatics, 2013, doi: 10.1093/bioin-formatics/btt620
51. van de Leemput IA, Wichers M, Cramer AO, Borsboom D, Tuerlinckx F, Kuppens P, van Nes EH, Viechtbauer W, Giltay EJ, Aggen SH, Derom C, Jacobs N, Kendler KS, van der Maas HL, Neale MC, Peeters F, Thiery E, Zachar P, Scheffer M. Critical slowing down as early warning for the onset and termination of depression. Proc Natl Acad Sci USA, 2014, 111: 87–92
52. Ichikawa S, Ito Y, Uchida K. Periodic Lyapunov differential equation for noise evaluation in oscillatory genetic networks. IEEE Control Applications (CCA) & Intelligent Control (ISIC), 2009. 83–88
53. Sejdic E. Medicine: adapt current tools for handling big data. Nature, 2014, 507: 306
54. Restifo NP. A “big data” view of the tumor “immunome”. Immunity, 2013, 39: 631–632
55. Gijzen H. Development: big data for a sustainable future. Nature, 2013, 502: 38
56. Boyle J. Biology must develop its own big-data systems. Nature, 2013, 499: 7
57. Marx V. Biology: the big challenges of big data. Nature, 2013, 498: 255–260
58. Buxton B, Hayward V, Pearson I, Karkkainen L, Greiner H, Dyson E, Ito J, Chung A, Kelly K, Schillace S. Big data: the next Google. Interview by Duncan Graham-Rowe. Nature, 2008, 455: 8–9
59. Ideker T, Krogan NJ. Differential network biology. Mol Syst Biol, 2012, 8: 565
60. Liu M, Liberzon A, Kong SW, Lai WR, Park PJ, Kohane IS, Kasif S. Network-based analysis of affected biological processes in type 2 diabetes models. PLoS Genet, 2007, 3: e96
61. Ulitsky I, Krishnamurthy A, Karp RM, Shamir R. DEGAS: de novo discovery of dysregulated pathways in human diseases. PLoS One, 2010, 5: e13367
62. Zhang B, Li H, Riggins RB, Zhan M, Xuan J, Zhang Z, Hoffman EP, Clarke R, Wang Y. Differential dependency network analysis to identify condition-specific topological changes in biological networks. Bioinformatics, 2009, 25: 526–532
63. Zhang B, Tian Y, Jin L, Li H, Shih Ie M, Madhavan S, Clarke R, Hoffman EP, Xuan J, Hilakivi-Clarke L, Wang Y. DDN: a caBIG(R) analytical tool for differential network analysis. Bioinformatics, 2011, 27: 1036–1038
64. Kim Y, Kim TK, Yoo J, You S, Lee I, Carlson G, Hood L, Choi S, Hwang D. Principal network analysis: identification of subnetworks representing major dynamics using gene expression data. Bioinformatics, 2011, 27: 391–398
65. West J, Bianconi G, Severini S, Teschendorff AE. Differential network entropy reveals cancer system hallmarks. Sci Rep, 2012, 2: 802
66. Sun SY, Liu ZP, Zeng T, Wang Y, Chen L. Spatio-temporal analysis of type 2 diabetes mellitus based on differential expression networks. Sci Rep, 2013, 3: 2268
67. Zeng T, Zhang CC, Zhang W, Liu R, Liu J, Chen L. Deciphering early development of complex diseases by progressive module network. Methods, 2014, http://dx.doi.org/10.1016/j.ymeth.2014.01.021